“Dr. is a kind, and patient Dr. Nice to see in younger generation. Back staff girls funny & kind. Reception kind too. Thank you for a good experience!”
Blood Thinners and Vitreous Hemorrhage: What You Need to Know
What Actually Causes the Bleeding
Understanding the true cause of a vitreous hemorrhage matters because it determines both urgency and treatment. Blood thinners are often the first thing patients suspect, but the underlying cause is almost always a structural or disease-related event inside the eye.
As the vitreous gel gradually shrinks with age, it slowly peels away from the retina in a process called a posterior vitreous detachment. Where the gel sticks too firmly to the retina, it can pull hard enough to tear the retinal tissue, and a torn retina often takes a small blood vessel with it. This is the most common sequence behind sudden, painless bleeding in people who do not have diabetes.
A retinal tear is also the reason bleeding is treated as urgent. The blood itself will clear over time. An undetected tear underneath it will not resolve on its own, and it needs to be found and sealed before the retina can lift away from the back of the eye.
In advanced diabetic retinopathy, the retina responds to poor blood supply by growing new blood vessels in a process called neovascularization. These vessels are fragile, grow in the wrong locations, and can bleed with little or no provocation. This is the single most common cause of vitreous hemorrhage overall, and unlike a simple torn vessel, it reflects an ongoing disease process that needs its own targeted treatment.
Blocked retinal veins, sickle cell disease, certain tumors, and bleeding related to abnormal vessels in macular degeneration account for much of the remaining cases. In each situation, the structure or health of the retinal vessels is the root of the problem.
Blood thinners do not damage blood vessels, and they do not cause new abnormal vessels to grow. They slow the clotting process, which means a vessel that is already torn or already leaking may bleed a little more or take longer to seal. This is an effect on the size of a bleed, not the cause of it. The research on whether that difference is meaningful is explained in the next section.
What the Research Shows
The evidence on blood thinners and vitreous hemorrhage is genuinely mixed, but the overall picture is more reassuring than most patients expect. Three sets of findings are worth understanding together.
In a retrospective review of 336 eyes with an acute vitreous detachment, vitreous hemorrhage was present in roughly 43 out of 100 people taking aspirin, clopidogrel, or warfarin, compared with about 31 out of 100 who were not taking these medications. That is a real difference. However, the same study did not demonstrate a statistically significant link between anticoagulant use and the presence of a retinal tear or detachment, which is the complication that actually threatens sight.
The two findings are worth separating. People on these medicines were more likely to arrive with blood visible in the eye. They were not shown to be more likely to have the underlying tear that puts vision at serious risk.
The strongest single piece of evidence points in the other direction. In a randomized controlled trial of 3,711 people with diabetic retinopathy, those assigned to 650 milligrams of aspirin daily were no more likely to experience bleeding into the gel or in front of the retina than those assigned to a placebo. The bleeds were not more severe, and they did not last longer.
This study specifically examined the group most people worry about: people whose retinas were already prone to bleeding. Even in that high-risk population, aspirin did not increase the rate or severity of vitreous hemorrhage.
A meta-analysis of 12 randomized trials involving more than 100,000 patients found that direct oral anticoagulants were associated with roughly one-fifth less bleeding inside the eye than warfarin. This compares one type of anticoagulant to another; it is not an argument against taking either. Which medication is right for a given patient depends on clot risk, kidney function, and other medications, and that decision belongs with the prescribing physician.
A clinical review published by the American Academy of Ophthalmology concludes that anticoagulation of any type has not been identified as a risk factor for vitreous hemorrhage, and that these medications are generally not stopped once a hemorrhage has developed. The practical takeaway is consistent across the evidence: a bleed in a patient on a blood thinner is examined, treated, and followed in the same way as any other bleed, and the medication continues doing its job throughout.
Symptoms and Warning Signs
Knowing what to watch for, and how quickly to act, can make a real difference in outcome. Vitreous hemorrhage is usually painless, which makes the visual symptoms the only early signal something is wrong.
Most people describe a sudden shower of floaters, dark specks, or a web-like haze drifting through their vision. A red or smoky tint over one eye is another common description. A small bleed may look like a scatter of dark dots. A larger one can reduce vision to shapes and light. Importantly, these symptoms are almost always in one eye only.
Blood settles downward under gravity over time. Keeping the head elevated, including during sleep, allows the blood to drop below the line of sight, which is why many patients notice vision is haziest first thing in the morning, when blood has spread out overnight, and clearer later in the day. These shifts are expected and do not mean anything new has gone wrong.
Some symptoms suggest the retina itself is involved, not just the gel in front of it. These warrant same-day contact with your eye doctor or urgent care.
- A dark curtain or shadow rising or spreading from one side of your vision
- A fixed area of missing vision that does not drift when you move your eye
- Vision that keeps worsening after the first day
- New flashing lights in one eye
- Eye pain or redness alongside any of the above
A simple vitreous hemorrhage does not usually cause pain or redness. When those are present alongside visual changes, it is a reason to be seen promptly rather than to wait.
How a Vitreous Hemorrhage Is Diagnosed
Diagnosis begins with a dilated eye examination, and the speed of that examination matters. The goal is not simply to confirm blood is present; it is to find out whether the retina has a tear.
Among people whose vitreous detachment comes with bleeding, roughly 50 to 70 out of 100 turn out to have a retinal tear, compared with only 7 to 12 out of 100 whose detachment had no bleeding. Blood in the eye significantly raises the chance that a tear is present. A tear found at that exam can be treated before the retina lifts away, which is the step that protects vision long-term.
When blood is dense enough to block the retina specialist's view of the back of the eye, a B-scan ultrasound is used to check whether the retina remains attached. A small probe rests on the closed eyelid over a thin layer of gel, takes only a few minutes, and involves no needles or dye. It cannot show a small tear the way a direct examination can, so the exam is repeated as blood clears.
Once the retina is accounted for, attention turns to why the bleed happened. Your retina specialist will examine both eyes, since diabetic changes are often present in both. Retinal imaging, including optical coherence tomography (OCT) and fluorescein angiography, a dye-based test that maps the retinal circulation, helps identify diabetic vessel disease, blocked veins, or other structural problems. A review of your current medications is a standard part of this process, used as information to understand your overall picture, not as a plan to change anything on its own.
Treatment Options and What to Expect
Treatment depends on what is found beneath the blood. Clearing the blood is only part of the work; the cause of the bleeding needs its own attention, or the eye is likely to bleed again.
If the retina is attached and no tear requires immediate treatment, the first step is usually observation. Blood leaves the vitreous gel gradually over time, and most patients manage this as outpatients, returning for scheduled follow-up visits as vision slowly improves. Keeping the head elevated during this period helps blood settle below the line of sight and out of the central field of vision.
A retinal tear is sealed with laser photocoagulation or cryopexy, a freezing treatment, to prevent the retina from detaching. Diabetic new vessels are treated with laser or with anti-VEGF injections, such as Avastin, Lucentis, Eylea, or Vabysmo, which shrink and stabilize the abnormal vessels. A blocked retinal vein is managed on its own terms. Without treating the underlying cause, recurrent bleeding is likely.
A vitrectomy is a surgical procedure that removes the vitreous gel along with the blood inside it. It is used when a retinal detachment is present, when blood has not cleared over a prolonged period, or when the blood is blocking treatment the retina urgently needs. Surgeons may also weigh earlier surgery when the other eye sees poorly and waiting leaves the patient unable to function day to day. Timing is often a genuine judgment call, and it is reasonable to ask your retina specialist to explain the reasoning in your specific case.
In most cases, nothing changes with your blood thinner. Clinical guidance indicates that anticoagulants, including aspirin, warfarin, and clopidogrel, are generally not discontinued once a vitreous hemorrhage has developed. A systematic review of 22 studies found the evidence nearly unanimous in recommending that patients continue their antiplatelet or anticoagulant medications even around eye surgery, because stopping them creates real risk of serious clotting events, while continuing them did not increase bleeding complications requiring a second operation.
If your retina specialist and your prescribing physician do want to review your medication together, that conversation belongs to all three of you, with your full clot and bleeding history on the table. It is not a decision to make unilaterally at home.
Risks, Complications, and the Realistic Outlook
Most people with a vitreous hemorrhage do well when the underlying cause is identified and treated. Understanding the realistic range of outcomes helps set the right expectations for the weeks and months ahead.
The greatest danger in a vitreous hemorrhage is not the blood itself. It is an untreated retinal tear hidden beneath it. A tear that goes undetected allows fluid to pass behind the retina and separate it from the back of the eye, a condition called retinal detachment. A detached retina requires surgery and is significantly harder to repair well than a tear that was sealed promptly. This is the reason for urgency, and it is also why follow-up appointments continue after the initial event.
Blood that remains in the eye for a long period, or that keeps returning, can create additional problems. Red blood cells and their breakdown products can block the eye's internal drainage system, raising pressure inside the eye. Iron deposits from blood breakdown can accumulate in eye tissue over time. Scar tissue can also form on the retinal surface. Each of these is manageable when monitored, which is why consistent follow-up care matters.
The prognosis depends far more on the cause of the hemorrhage than on the blood itself. Conditions that do not cause repeated bleeding generally carry a better outlook. Eyes bleeding from active proliferative diabetic retinopathy tend to do less well overall, particularly without treatment of the underlying vessels. These general patterns do not predict any individual result; the findings of your own examination determine your specific picture.
Frequently Asked Questions
These answers address common concerns and decision points that come up after a diagnosis of vitreous hemorrhage, particularly for patients on blood-thinning medications.
No. Do not stop or reduce your blood thinner on your own because of an eye symptom. The clot, stroke, or cardiac event your medication is preventing poses a much greater immediate danger than an eye bleed, and that risk returns quickly once doses are missed. Bring your medication list or the actual bottles to your appointment so the care team has a complete picture. Any adjustment to your medication is a decision made by the physician who prescribed it, in conversation with your eye care team, after weighing your full medical history.
Almost certainly not by itself. Blood thinners do not injure blood vessels or cause abnormal vessels to grow. Something else opened a vessel first, most commonly a vitreous detachment tearing the retina, diabetic new vessel disease, or an injury. Your medication may have made a bleeding vessel slower to seal, but it was not the cause of the event. Your retina specialist's goal at the examination is to find what actually caused the bleed, because that is what determines treatment and the risk of it happening again.
Expect weeks to months rather than days. Blood leaves the vitreous gel gradually, and a dense hemorrhage can take a long time to clear on its own. Vision commonly improves in stages and may seem worse in the morning, when blood has spread out during sleep, then slightly better later in the day. If blood has not cleared after a prolonged period, or if the retina needs treatment that the blood is blocking, surgical removal of the gel becomes an option worth discussing with your retina specialist.
It should be treated as urgent, even though it is not always a life-threatening emergency. The concern is not the blood itself but the retinal tear that is frequently found beneath it. Among people whose vitreous detachment comes with bleeding, the majority turn out to have a tear. A tear found promptly can usually be sealed in the office. A tear left undetected can progress to a retinal detachment, which requires surgery and is much harder to repair with full visual recovery. Contact your eye doctor the same day symptoms begin.
That depends on the cause. A bleed from a retinal tear that has been properly sealed is unlikely to repeat from that same tear. Bleeding from diabetic neovascularization tends to recur until the abnormal vessels are treated with laser or anti-VEGF injections, which is why treating those vessels is the real solution rather than simply waiting for blood to clear each time. Your retina specialist can tell you which situation applies to you and what follow-up is needed to reduce the chance of recurrence.
The answer depends on what your retina specialist found during your examination, so follow their specific guidance rather than general advice. Keeping the head elevated, including during sleep, is commonly recommended to help blood settle out of the central line of sight. Any restrictions on physical activity are typically related to protecting a retinal tear or a surgical repair, not the blood itself. If a tear or detachment was identified, expect more specific and stricter instructions, and follow those carefully.
Visit Atlantic Retina Center for Expert Retinal Care
Our team of fellowship-trained, ABO board-certified retina specialists at Atlantic Retina Center is dedicated exclusively to the care of the retina, vitreous, and macula, bringing focused expertise to every examination. If you are experiencing sudden floaters, vision changes, or have questions about how your medications interact with your eye health, we encourage you to reach out and schedule a prompt evaluation at one of our offices serving the Eastern Shore of Maryland and central and southern Delaware. Early evaluation is the most important step you can take to protect your vision.